Insulet, a medical device company that develops, manufactures, and markets an innovative, discreet and easy-to-use insulin infusion system, filed for an IPO Wednesday. J.P. Morgan and Merrill Lynch are the joint lead managers on the deal. Terms and timing are yet to be announced.
